TARA Mind, a Mclean, VA-based public benefit corporation focused on creating access to safe and effective ketamine-assisted therapy (KAT), raised $8M in Seed funding.
The round was led by Satori Neuro. Additional investors participating in the round were Echo Investment Capital, Crumpton Ventures, Empath Ventures, and Blake Mykoskie.
The company intends to use the funds to expand operations and ts business reach.
founded in 2022 by investment and incubation firm Red Cell Partners led by Grant Verstandig (TARA Mind Co-founder) and Dr. Yisroel Brumer and led by Marcus Capone, TARA Mind is advancing its mission to provide safe, effective, and affordable access to life-changing mental health therapies through its collaborative care platform and structured real world evidence dataset. The company has developed a mental health collaborative care platform, recognized for being clinician-guided, data-driven and evidence-based, to help the millions of individuals struggling with mental health disorders that have not been clinically responsive to traditional mental health therapies. Many of these individuals represent the highest risk/highest cost segment of the workforce. Self-funded employers who offer TARA Mind’s benefit can expect to realize favorable ROI results within the first year. Employer savings are derived from reduced medical costs, reduced absenteeism, and improved workforce productivity.
FinSMEs
24/01/2024